Gene · 638
Papers2,521
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,521
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [A clinical Case and brief literature review of Icenko-Cushing's Disease in a pediatric patient with atypical onset of the disease]. | Probl Endokrinol (Mosk) | 2022 | 36104970 | PubTator, text mining | PubMed |
| Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets. | J Hematol Oncol | 2022 | 36104717 | PubTator, text mining | PubMed |
| Prolonged, Low-Level Exposure to the Marine Toxin, Domoic Acid, and Measures of Neurotoxicity in Nonhuman Primates. | Environ Health Perspect | 2022 | 36102641 | PubTator, text mining | PubMed |
| An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia. | PLoS Comput Biol | 2022 | 36099249 | PubTator, text mining | PubMed |
| Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes. | Transpl Int | 2022 | 36090777 | PubTator, text mining | PubMed |
| Higher susceptibility of males to bleomycin-induced pulmonary inflammation is associated with sex-specific transcriptomic differences in myeloid cells. | Toxicol Appl Pharmacol | 2022 | 36087614 | PubTator, text mining | PubMed |
| Mechanism of Citri Reticulatae Pericarpium as an Anticancer Agent from the Perspective of Flavonoids: A Review. | Molecules | 2022 | 36080397 | PubTator, text mining | PubMed |
| Small-Molecule PROTACs for Cancer Immunotherapy. | Molecules | 2022 | 36080223 | PubTator, text mining | PubMed |
| A Review on Traditionally Used African Medicinal Plant Annickia chlorantha, Its Phytochemistry, and Anticancer Potential. | Plants (Basel) | 2022 | 36079675 | PubTator, text mining | PubMed |
| Apoptosis evasion via long non-coding RNAs in colorectal cancer. | Cancer Cell Int | 2022 | 36076273 | PubTator, text mining | PubMed |
| Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation. | Nat Genet | 2022 | 36071171 | PubTator, text mining | PubMed |
| Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications. | Front Oncol | 2022 | 36059609 | PubTator, text mining | PubMed |
| Solanum nigrum Linn.: An Insight into Current Research on Traditional Uses, Phytochemistry, and Pharmacology. | Front Pharmacol | 2022 | 36052142 | PubTator, text mining | PubMed |
| Exploring new pathways in endocrine-resistant breast cancer. | Explor Target Antitumor Ther | 2022 | 36045911 | PubTator, text mining | PubMed |
| Deoxypodophyllotoxin Induces ROS-Mediated Apoptosis by Modulating the PI3K/AKT and p38 MAPK-Dependent Signaling in Oral Squamous Cell Carcinoma. | J Microbiol Biotechnol | 2022 | 36039387 | PubTator, text mining | PubMed |
| The effect of valproic acid on intrinsic, extrinsic, and JAK/STAT pathways in neuroblastoma and glioblastoma cell lines. | Res Pharm Sci | 2022 | 36034083 | PubTator, text mining | PubMed |
| Human Cytomegalovirus and Human Herpesvirus 6 Coinfection of Dermal Fibroblasts Enhances the Pro-Inflammatory Pathway Predisposing to Fibrosis: The Possible Impact on Systemic Sclerosis. | Microorganisms | 2022 | 36014018 | PubTator, text mining | PubMed |
| Post-Transcriptional Modifications of RNA as Regulators of Apoptosis in Glioblastoma. | Int J Mol Sci | 2022 | 36012529 | PubTator, text mining | PubMed |
| Role of Caspase Family in Intervertebral Disc Degeneration and Its Therapeutic Prospects. | Biomolecules | 2022 | 36008968 | PubTator, text mining | PubMed |
| A systematic review of anti-cancer roles and mechanisms of kaempferol as a natural compound. | Cancer Cell Int | 2022 | 35986346 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/638/papers?page=17